Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Miguel A. Gomez-Sanchez
Effects of Inhaled Aviptadil (Vasoactive Intestinal Peptide) in Patients With Pulmonary Arterial Hypertension (PAH)
Related publications
Inhalation of Vasoactive Intestinal Peptide in Pulmonary Hypertension
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
P2 In-Flight Hypoxaemia in Patients With Pulmonary Arterial Hypertension (PAH)
Thorax
Pulmonary
Respiratory Medicine
Pulmonary Clearance of Vasoactive Intestinal Peptide.
Thorax
Pulmonary
Respiratory Medicine
Rapid Transition From Inhaled Iloprost to Inhaled Treprostinil in Patients With Pulmonary Arterial Hypertension
Cardiovascular Therapeutics
Medicine
Cardiovascular Medicine
Pharmacology
Cardiology
Tolerability and Clinical Efficacy of Inhaled Treprostinil in Patients With Group 1 Pulmonary Arterial Hypertension
Therapeutic Advances in Chronic Disease
Medicine
Withdrawal of Long-Term Epoprostenol Therapy in Pulmonary Arterial Hypertension (PAH)
Pulmonary Circulation
Pulmonary
Respiratory Medicine
Inhaled Iloprost for Treatment of Pulmonary Arterial Hypertension
Advances in Pulmonary Hypertension
Development of a New Patient-Reported Outcome (PRO) Instrument for Pulmonary Arterial Hypertension (PAH): The Pulmonary Arterial Hypertension–symptoms and Impact (PAH-SYMPACT) Questionnaire
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Characterizing Patients Treated With Macitentan for Pulmonary Arterial Hypertension (PAH) in the U.S. Opsumit Users Registry (OPUS)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
